Kaufman Bros. Starts Conceptus (CPTS) at Hold; Balancing Sales & Marketing Programs Needed to Drive Growth as Patients Continue to Hide

Article Stock Quotes (2) Comments (0)

Kaufman Bros. initiates coverage on Conceptus (NASDAQ: CPTS) with a Hold. PT $11.00.

Kaufman analyst says, "On lingering softness in physician office visits, as well as tough competition from Hologic (Nasdaq: HOLX)(BUY), Conceptus invests in both offensive and defensive sales and marketing programs to drive negative-to-low-single digit revenue gains in 2011E-2013E, down from historic 25%+ increases, pressuring operating profit margin expansion. CPTS is also trading at a premium to comparable small cap MedTech growth averages vis-a-vis its now slower growth outlook."

For more ratings news on Conceptus click here and for the rating history of Conceptus click here.

Shares of Conceptus closed at $10.37 yesterday, with a 52 week range of $9.75-$15.78.

---

Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW

---

*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here

---

---

You May Also Be Interested In

• Deutsche Bank Resumes CenterPoint Energy (CNP) at Hold
• Roth Capital Resumes Kid Brands (KID) at Neutral
• Topeka Capital Starts CEVA Inc. (CEVA) at Buy

Create E-mail Alert Related Categories

New Coverage

Related Entities

Kaufman Bros.

Add Your Comment

Name

Subject

Body

Share on Facebook

Verification
can't see the text?
click here to refresh the image.
what's this?